Cargando…
JUPITER‐02 trial: advancing survival for recurrent metastatic nasopharyngeal carcinoma and next steps
Autores principales: | Tan, Laura Ling Ying, Le, Quynh‐Thu, Lee, Nancy Ying Ying, Chua, Melvin Lee Kiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8753315/ https://www.ncbi.nlm.nih.gov/pubmed/34918497 http://dx.doi.org/10.1002/cac2.12248 |
Ejemplares similares
-
Gemcitabine improves survival in patients with recurrent or metastatic nasopharyngeal carcinoma
por: Hong, Shaodong, et al.
Publicado: (2016) -
Surgery as an alternative to radiotherapy in early‐stage nasopharyngeal carcinoma: innovation at the expense of uncertainty
por: Huang, Luo, et al.
Publicado: (2020) -
The next step towards usable microbial bioelectrochemical sensors?
por: Arends, Jan B. A.
Publicado: (2017) -
Optimal sequencing of chemotherapy with chemoradiotherapy based on TNM stage classification and EBV DNA in locoregionally advanced nasopharyngeal carcinoma
por: Liu, Li-Ting, et al.
Publicado: (2019) -
A two‐step infection model: From SARS‐CoV‐2 entry and trafficking to egress and spread
por: You, Liting, et al.
Publicado: (2023)